Insider Transactions Reported by 13 Insiders of Klotho Neurosciences, Inc.

Symbol
KLTO, KLTOW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1115 Broadway, 12 Th Floor, New York, NY

There are no Buy or Sell transactions made by insiders since 12/10/2024

Klotho Neurosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Redwoods Capital LLC 10%+ Owner $31.2M Apr 7, 2022
Joseph Sinkule Chief Executive Officer, Director $3.54M Sep 25, 2025
Chardan Capital Markets Llc 10%+ Owner $2.63M Jun 28, 2024
Samuel Zentman Director $982K Dec 10, 2025
Jeff LeBlanc Chief Financial Officer $911K Aug 25, 2025
Shalom Hirschman Director $727K Aug 5, 2025
Jiande Chen Chief Executive Officer, Director $450K Mar 30, 2022
Edward Cong Wang Chief Financial Officer, Director $350K Mar 30, 2022
Raymond J. Gibbs Director $350K Mar 30, 2022
Hong Li Director $300K Mar 30, 2022
Ng Weikwang Director $300K Mar 30, 2022
Jon McGarity Director $85.2K Dec 10, 2025
Riad El-Dada Director $24.6K Dec 10, 2025

Recent Insider Transactions by Companies or Individuals for Klotho Neurosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.